Biological intercomparisons of neutron beams used for radiotherapy generated by p(+)-->Be in hospital-based cyclotrons.
The new generation of hospital-based neutron therapy facilities involve cyclotrons using protons on beryllium. The spectrum of neutrons produced includes a large and variable proportion of low-energy neutrons that are poorly penetrating but biologically effective. Cells cultured in vitro were used to compare the three US facilities at Seattle, M.D. Anderson and UCLA, together with the UK facility at Clatterbridge. Cyclotrons were compared within a given experiment on the same day using cells from a common suspension. Among the three US facilities, the relative potency factor at a depth of 25 mm differs by about 11%, with Seattle the least and UCLA the most biologically effective. Clatterbridge was compared directly with M.D. Anderson and found to be less effective by about 5%; it has a slightly lower biological effectiveness than any of the US facilities. There is evidence for an increased biological effectiveness in the build-up region, which reduces the effective skin sparing potential. There is not much difference in build-up between the three US facilities. Using the proton-on-beryllium neutron production process results in a wide spectrum of neutrons with a large but variable low-energy component. The biological effectiveness of the beam depends on target design and thickness as well as the design of the collimating system. Consequently the biological effectiveness of neutron beams generated by this process must be assessed on an individual basis. It cannot be assumed that because cyclotrons have similar accelerating energies that the relative biological effectiveness will be the same.
Hall
E J
EJ
Center for Radiological Research, College of Physicians & Surgeons of Columbia University, New York, NY.
Astor
M
M
Brenner
D J
DJ
D000818:Animals; D001608:Beryllium / Q000627:therapeutic use*; D002460:Cell Line; D002470:Cell Survival / Q000528:radiation effects; D006224:Cricetinae; D017357:Cyclotrons; D004307:Dose-Response Relationship, Radiation; D004739:England; D005347:Fibroblasts / Q000473:pathology / Q000528:radiation effects; D015141:Los Angeles; D008961:Models, Structural; D009502:Neutrons; D009684:Nuclear Medicine Department, Hospital; D011522:Protons; D011868:Radioisotopes / Q000627:therapeutic use*; D011879:Radiotherapy Dosage; D011882:Radiotherapy, High-Energy; D013781:Texas; D014861:Washington
D011522:Protons; D011868:Radioisotopes; D001608:Beryllium